Acumen Pharmaceuticals ABOS
- sabirnetug — Alzheimer's Disease Phase 2
- sabirnetug — Alzheimer's Disease Phase 1
- ACU301 — Alzheimer's Disease Preclinical
- ACU401 — Alzheimer's Disease Preclinical
Home › Targets › amyloid beta oligomers
amyloid beta oligomers (2 companies · 5 programs)
Companies with an active program directed at amyloid beta oligomers.
ProMIS Neurosciences Inc. PMN
- PMN310 — Alzheimer's Disease Phase 1